Takako Onoki

Saudi Arabian Oil Company (Saudi Aramco), the world's largest oil company by production, in its US$69.1 billion acquisition of a 70% stake in Saudi Basic Industries Corporation (SABIC), one of the world's largest chemicals companies, from the Public Investment Fund, the sovereign wealth fund of the Kingdom of Saudi Arabia.

Panasonic Corporation on its acquisition of the remaining 80% of the capital stock interests of Blue Yonder, a leading end-to-end, digital fulfillment platform provider, at an enterprise value of US$8.5 billion on a cash-free, debt-free basis. This transaction adds to the 20% stake of Blue Yonder which Panasonic Corporation acquired in July 2020, also represented by White & Case.

Canon Medical Systems Corp. (CMSC), a Japanese medical equipment company, on its agreement with leading Russian healthcare provider R-Pharm Holding, LLC (RPH) to establish a diagnostic imaging equipment joint venture that covers nine members of the Commonwealth of Independent States (CIS), including Russia.

Panasonic Corporation in its 20% strategic equity investment in Blue Yonder with an estimated enterprise value of US$5.5 billion.

DIC Corporation, a Japanese fine chemicals company, and its US subsidiary Sun Chemical Corporation, in connection with DIC's proposed acquisition of BASF’s global pigments business, known as BASF Colors & Effects (BCE). The purchase price on a cash and debt-free basis is €1.15 billion.

Kato Kagaku Co., Ltd., a Japanese company engaged in the manufacture and sale of cornstarch, in connection with a price-fixing claim filed against Kato Kagaku by the Japan Fair Trade Commission (JFTC) as part of the JFTC's investigation into an alleged cartel in the cornstarch. First and only case in which the JFTC overturned its surcharge payment order entirely.

Maruyasu Industries Co., Ltd., a Japanese auto parts manufacturer, in a US DOJ Antitrust Division's grand jury investigation and subsequent prosecution for alleged price-fixing, bid-rigging, and market allocation.

Zimmer Holdings, Inc. (renamed Zimmer Biomet Holdings, Inc.), in obtaining regulatory clearance from the US Federal Trade Commission, European Commission and JFTC for its US$14 billion acquisition of Biomet, Inc. This transaction received a "Commended" ranking by the Financial Times in its FT North America Innovative Lawyers 2015 report, and represented one of the largest transactions in the medical devices sector, impacting hundreds of markets worldwide.

Toys"R"Us-Japan, Ltd. in a JFTC investigation and subsequent appeal in connection with certain business practices under the Antimonopoly Act.